Conference Coverage

Four lifestyle changes might prevent 40% of heart failure

Publish date: November 3, 2014

 

EXPERT ANALYSIS FROM THE HFSA ANNUAL SCIENTIFIC MEETING

References

He reported receiving research support from Merck and GlaxoSmithKline and serving as a consultant to Bayer.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

20-study analysis finds no MACE increase with saxagliptin
MDedge Endocrinology
In diabetes, women far more likely to develop CHD than men
MDedge Endocrinology
Fatty heart may bring on diabetes
MDedge Endocrinology
ZS-9 may be a safer hyperkalemia therapy
MDedge Endocrinology
FDA’s olmesartan probe showed no increased CV risk in diabetes
MDedge Endocrinology
Systemwide disparities seen in diagnosis, care of women with heart disease
MDedge Endocrinology
Reassuring results on cardiovascular safety of DPP-4 inhibitors
MDedge Endocrinology
Type 2 diabetes boosts risk of death in heart failure patients by 70%
MDedge Endocrinology
FDA finalizes medical device cybersecurity guidance
MDedge Endocrinology
Myocardial geometry, function altered in obese children
MDedge Endocrinology